Cochrane · systematic review · CD001132

5‐Fluorouracil for glaucoma surgery

Green, E, Wilkins, M, Bunce, C, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
36
current version
GRADE rated
29
No studies
7
Included studies
NR
No studies 7 · 19.4%Ungraded 0 · 0%Very low 5 · 13.9%Low 11 · 30.6%Moderate 9 · 25%High 4 · 11.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Regular‐dose postoperative 5‐Fluorouracil versus control for glaucoma surgery

Population: participants with glaucoma surgery
6 questions
OutcomeEffectEvidenceStatus / GRADE
Failure at 12 months
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 0.39 [0.26, 0.58]6 studies · 469 participantsLow
Downgraded: risk of bias
Mean intraocular pressure at 12 months
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies
Complications ‐ wound leak
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 1.38 [0.93, 2.04]6 studies · 469 participantsLow
Downgraded: risk of bias
Complications ‐ hypotonous maculopathy
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies
Complications ‐ shallow anterior chamber
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 1.84 [0.76, 4.46]6 studies · 469 participantsLow
Downgraded: risk of bias
Complications ‐ epithelial toxicity
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 1.56 [1.36, 1.78]6 studies · 469 participantsLow
Downgraded: risk of bias

Regular‐dose postoperative 5‐Fluorouracil versus control for glaucoma surgery ‐ high risk of failure subgroup

Population: participants with glaucoma surgery
6 questions
OutcomeEffectEvidenceStatus / GRADE
Failure at 12 months ‐ high risk of failure
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 0.44 [0.29, 0.68]2 studies · 239 participantsModerate
Downgraded: risk of bias
Mean intraocular pressure at 12 months ‐ high risk of failure
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted1 study · 26 participantsModerate
Downgraded: risk of bias
Complications ‐ wound leak ‐ high risk of failure
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 1.64 [1.04, 2.58]2 studies · 239 participantsModerate
Downgraded: risk of bias
Complications ‐ hypotonous maculopathy ‐ high risk of failure ‐ not reported
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies
Complications ‐ shallow anterior chamber ‐ high risk of failure
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 2.41 [0.88, 6.58]2 studies · 239 participantsModerate
Downgraded: risk of bias
Complications ‐ epithelial toxicity ‐ high risk of failure
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 1.25 [1.12, 1.38]2 studies · 239 participantsModerate
Downgraded: risk of bias

Regular‐dose postoperative 5‐Fluorouracil versus control for glaucoma surgery ‐ combined surgery subgroup

Population: participants with glaucoma surgery
6 questions
OutcomeEffectEvidenceStatus / GRADE
Failure at 12 months ‐ combined surgery
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted2 studies · 118 participantsVery low
Downgraded: risk of bias
Mean intraocular pressure at 12 months ‐ combined surgery
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted2 studies · 118 participantsLow
Downgraded: risk of bias
Complications ‐ wound leak ‐ combined surgery
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 0.9 [0.36, 2.23]2 studies · 118 participantsLow
Downgraded: risk of bias
Complications ‐ hypotonous maculopathy ‐ combined surgery ‐ not reported
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies
Complications ‐ shallow anterior chamber ‐ combined surgery
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted2 studies · 118 participantsVery low
Downgraded: risk of bias
Complications ‐ epithelial toxicity ‐ combined surgery
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 3.04 [1.56, 5.92]2 studies · 118 participantsLow
Downgraded: risk of bias

Regular‐dose postoperative 5‐Fluorouracil versus control for glaucoma surgery ‐ primary trabeculectomy subgroup

Population: participants with glaucoma surgery
6 questions
OutcomeEffectEvidenceStatus / GRADE
Failure at 12 months ‐ primary trabeculectomy
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 0.21 [0.06, 0.68]2 studies · 112 participantsModerate
Downgraded: risk of bias
Mean intraocular pressure at 12 months ‐ primary trabeculectomy
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted2 studies · 112 participantsLow
Downgraded: risk of bias
Complications ‐ wound leak ‐ primary trabeculectomy
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 0.47 [0.04, 4.91]2 studies · 112 participantsLow
Downgraded: risk of bias
Complications ‐ hypotonous maculopathy ‐ primary trabeculectomy
Regular‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted1 study · 62 participantsModerate
Downgraded: risk of bias
Complications ‐ shallow anterior chamber ‐ primary trabeculectomy
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 0.47 [0.04, 4.91]2 studies · 112 participantsLow
Downgraded: risk of bias
Complications ‐ epithelial toxicity ‐ primary trabeculectomy
Regular‐dose postoperative 5‐Fluorouracil vs control
RR 5.85 [2.04, 16.83]2 studies · 112 participantsLow
Downgraded: risk of bias

Low‐dose postoperative 5‐Fluorouracil versus control for glaucoma surgery

Population: participants with glaucoma surgery
6 questions
OutcomeEffectEvidenceStatus / GRADE
Failure at 12 months
Low‐dose postoperative 5‐Fluorouracil vs control
RR 0.93 [0.7, 1.24]1 study · 76 participantsVery low
Downgraded: risk of bias
Mean intraocular pressure at 12 months
Low‐dose postoperative 5‐Fluorouracil vs control
no estimate extracted1 study · 76 participantsVery low
Downgraded: risk of bias
Complications ‐ wound leak
Low‐dose postoperative 5‐Fluorouracil vs control
RR 0.33 [0.01, 7.93]1 study · 76 participantsVery low
Downgraded: risk of bias
Complications ‐ hypotonous maculopathy ‐ not reported
Low‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies
Complications ‐ shallow anterior chamber ‐ not reported
Low‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies
Complications ‐ epithelial toxicity ‐ not reported
Low‐dose postoperative 5‐Fluorouracil vs control
no estimate extractedNRNo studies

Intraoperative 5‐Fluorouracil versus placebo or control for glaucoma surgery

Population: participants with glaucoma surgery
6 questions
OutcomeEffectEvidenceStatus / GRADE
Failure at 12 months Need for repeat surgery or uncontrolled IOP (usually more than 22 mm Hg) despite additional topical or systemic medications
Intraoperative 5‐Fluorouracil vs placebo or control
RR 0.68 [0.51, 0.92]4 studies · 711 participantsHigh
Mean intraocular pressure at 12 months
Intraoperative 5‐Fluorouracil vs placebo or control
no estimate extracted4 studies · 711 participantsHigh
Complications ‐ wound leak
Intraoperative 5‐Fluorouracil vs placebo or control
RR 1.36 [1, 1.84]4 studies · 711 participantsHigh
Complications ‐ hypotonous maculopathy
Intraoperative 5‐Fluorouracil vs placebo or control
RR 1.47 [0.42, 5.12]4 studies · 711 participantsModerate
Complications ‐ shallow anterior chamber
Intraoperative 5‐Fluorouracil vs placebo or control
RR 1.99 [1.22, 3.22]4 studies · 711 participantsHigh
Complications ‐ epithelial toxicity
Intraoperative 5‐Fluorouracil vs placebo or control
RR 1.23 [0.85, 1.77]4 studies · 711 participantsModerate